Latvia Inese Bolmane, business development manager at Latvian stem cell bank Cilmes Šūnu Banka, explains the basic rationale behind stem cell banking and what differentiates Cilmes Šūnu Banka from the competition. Could you please start by introducing the Cilmes Šūnu Banka? “One positive by-product of increased competition is that our competitors…
Pharma Stem cell technology can play a key role in improving the drug discovery process. The CEO of Pluriomics, a biotech company focused on development of fully functional human assay systems for use in drug discovery and development, explains the vision behind the creation of the company as well as the…
Pharma Stem cell therapy holds the promise to treat diseases for which there are currently no or only limited therapeutic options. Christine Mummery, Professor of Developmental Biology and Chair of the Department of Anatomy and Embryology at the Leiden University Medical Center, discusses how academia and industry can work together to…
stem cell The founder of MEDIPOST, the producer of the only approved allogenic stem cell product in the world, disucsses their development goals for the coming years and the potential for regenerative medicine to revolutionize a variety of healthcare practices. Dr. Yang, to begin, could you please introduce yourself and MEDIPOST to…
Bionet Corp. The chairman of Bionet reflects on past market challenges and the growing strength of Bionet’s reach both domestically and globally, and why Taiwan is the perfect size for a biotech start-up, despite its strict regulatory environment. Bionet is a cord blood banking pioneer in Taiwan. What is the story of…
Biopharmaceuticals Over the past decade since its founding, what are some of the highlights in the transformation of Taiwan Advance Bio-Pharmaceutical Inc. (TABP) into a well established company? TABP was founded in 2000 as a spinoff of the Development Center for Biotechnology (DCB). The DCB was established in 1984 to support…
See our Cookie Privacy Policy Here